Togliattiazot Launched COVID-19 Inoculation
The vaccination is carried out at the premises of outpatient clinic No. 4 in the Komsomolsk district of Togliatti, using Russia’s Sputnik V vaccine (Gam-COVID-Vac) developed by the Gamaleya Research Institute of Epidemiology and Microbiology under the Russian Health Ministry. The company collects applications of those wishing to undergo the procedure and arranges their delivery by corporate transport. As of today, 180 employees have already been included in the waiting list, of which 75 persons have passed the first stage of vaccination.
“Togliattiazot is still focused on ensuring safety of its production lines and its employees under challenging conditions of the ongoing coronavirus epidemic,” said Sergey Gulkin, Deputy General Director – HR Director at JSC Corporation Togliattiazot. “The company has already allocated more than RUB 79 million for these purposes, as we have purchased PPEs for employees, infrared scanners and bactericidal agents, increased the frequency of disinfection in the premises, and arranged the delivery of employees with respect to social distance. Currently, we put an emphasis on preventive measures and make it possible for our employees to protect themselves and those around them through inoculation. I hope that they will take a responsible approach to the decision on vaccination.”
Togliattiazot will continue with voluntary vaccination of its employees.
Togliattiazot, a leading producer of ammonia and urea in Russia and one of the major employers in Togliatti, has started a vaccination campaign against a new coronavirus infection (COVID-19) for its employees on a voluntary basis.
Togliattiazot , a leading producer of ammonia and urea in Russia and a backbone enterprise in Togliatti, will adjust the salaries of its employees by 5 percent in accordance with Article 134 of the Labour Code of the Russian Federation and as part of its obligations under the collective agreement dated 1 February 2021.
PJSC TOAZ updated records in the output and shipment of the core products.